drug · antibody
patient view →suvratoxumab
Phase 2updated 2mo agoby Aridis Pharmaceuticals Inc🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Phase 3 (across all indications), with 3 investigational indications.
targets
Alpha-hemolysin
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that